Last updated: 15 August 2024 at 5:12pm EST

Robert Carey Net Worth




The estimated Net Worth of Robert Carey is at least $3.27 Million dollars as of 14 August 2024. Mr. Carey owns over 100,000 units of Sangamo Therapeutics Inc stock worth over $2,584,566 and over the last 11 years he sold SGMO stock worth over $509,882. In addition, he makes $176,312 as Independent Director at Sangamo Therapeutics Inc.

Mr. Carey SGMO stock SEC Form 4 insiders trading

Robert has made over 26 trades of the Sangamo Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 100,000 units of SGMO stock worth $40,000 on 14 August 2024.

The largest trade he's ever made was buying 1,200,000 units of Sangamo Therapeutics Inc stock on 18 December 2023 worth over $1,968,000. On average, Robert trades about 42,201 units every 45 days since 2014. As of 14 August 2024 he still owns at least 3,076,864 units of Sangamo Therapeutics Inc stock.

You can see the complete history of Mr. Carey stock trades at the bottom of the page.





Robert Carey biography

Robert F. Carey is Independent Director of the Company. Mr. Carey served as executive vice president, chief business officer for Horizon Pharma plc, a biopharmaceutical company, from March 2014 to October 2019. Prior to that, he served as managing director and head of the healthcare investment banking group at JMP Securities LLC, a full-service investment bank from March 2003 to March 2014. Prior to JMP, Mr. Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities International, Inc. He has also held roles at Shearson Lehman Hutton and Ernst & Whinney. Mr. Carey also serves on the board of directors of Beyond Air, Inc. (formerly AIT Therapeutics, Inc.). Mr. Carey received his B.S. in accounting from the University of Notre Dame. The Nominating and Corporate Governance Committee and the Board believe that Mr. Carey’s extensive experience and knowledge in the healthcare investment banking industry, particularly with financings, global expansion and other strategic transactions by life-science companies, as well as his role in business development for a public biopharmaceutical company, provides the Board with valuable insight and contribution.

What is the salary of Robert Carey?

As the Independent Director of Sangamo Therapeutics Inc, the total compensation of Robert Carey at Sangamo Therapeutics Inc is $176,312. There are 10 executives at Sangamo Therapeutics Inc getting paid more, with Alexander Macrae having the highest compensation of $3,986,560.



How old is Robert Carey?

Robert Carey is 61, he's been the Independent Director of Sangamo Therapeutics Inc since 2016. There are 1 older and 17 younger executives at Sangamo Therapeutics Inc. The oldest executive at Sangamo Therapeutics Inc is H. Stewart Parker, 64, who is the Independent Director.

What's Robert Carey's mailing address?

Robert's mailing address filed with the SEC is C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530.

Insiders trading at Sangamo Therapeutics Inc

Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over $87,969,621 worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth $48,483,268 . The most active insiders traders include Capital Management, L.P.Ra ..., Le Roy C Kopp, and Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of $40,671. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth $3,000,000.



What does Sangamo Therapeutics Inc do?

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.



What does Sangamo Therapeutics Inc's logo look like?

Sangamo Therapeutics Inc logo

Complete history of Mr. Carey stock trades at Horizon Therapeutics Plc, Sangamo Therapeutics Inc, and Beyond Air

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
14 Aug 2024 Robert Carey
Director
Buy 100,000 $0.40 $40,000
14 Aug 2024
3,076,864
18 Dec 2023 Robert Carey
Director
Buy 1,200,000 $1.64 $1,968,000
18 Dec 2023
2,374,454
28 Aug 2023 Robert Carey
Director
Buy 250,000 $2.70 $675,000
28 Aug 2023
1,225,160
18 Aug 2023 Robert Carey
Director
Buy 88,664 $2.75 $243,826
18 Aug 2023
975,160
29 Mar 2023 Robert Carey
Director
Buy 20,000 $6.38 $127,600
29 Mar 2023
886,496
13 Mar 2023 Robert Carey
Director
Buy 14,173 $6.64 $94,109
13 Mar 2023
866,496
8 Mar 2023 Robert Carey
Director
Buy 10,000 $5.95 $59,500
8 Mar 2023
852,323
7 Dec 2022 Robert Carey
Director
Buy 20,000 $5.75 $115,000
7 Dec 2022
842,323
28 Nov 2022 Robert Carey
Director
Buy 30,000 $5.75 $172,500
28 Nov 2022
822,323
16 Nov 2022 Robert Carey
Director
Buy 50,000 $5.88 $294,000
16 Nov 2022
792,323
30 Jun 2022 Robert Carey
Director
Buy 175,000 $6.45 $1,128,750
30 Jun 2022
742,323
5 Apr 2022 Robert Carey
Director
Buy 20,000 $6.71 $134,200
5 Apr 2022
567,323
24 Mar 2022 Robert Carey
Director
Buy 26,185 $6.64 $173,868
24 Mar 2022
547,323
17 Mar 2022 Robert Carey
Director
Buy 20,000 $6.75 $135,000
17 Mar 2022
521,138
22 Dec 2021 Robert Carey
Director
Buy 10,000 $9.50 $95,000
22 Dec 2021
518,418
23 Nov 2021 Robert Carey
Director
Buy 5,000 $12.35 $61,750
23 Nov 2021
508,418
22 Nov 2021 Robert Carey
Director
Buy 10,000 $12.05 $120,500
22 Nov 2021
503,418
19 Nov 2021 Robert Carey
Director
Buy 12,000 $14.10 $169,200
19 Nov 2021
493,418
17 Jun 2021 Robert Carey
Director
Buy 350,000 $5.36 $1,876,000
17 Jun 2021
481,418
4 Mar 2021 Robert Carey
Director
Buy 17,000 $5.70 $96,900
4 Mar 2021
131,418
18 Feb 2021 Robert Carey
Director
Buy 15,000 $6.67 $100,050
18 Feb 2021
114,418
24 Aug 2020 Robert Carey
Director
Buy 10,000 $5.70 $57,000
24 Aug 2020
99,418
14 Aug 2020 Robert Carey
Director
Buy 60,000 $5.63 $337,800
14 Aug 2020
89,418
13 Aug 2020 Robert Carey
Director
Buy 10,000 $5.38 $53,800
13 Aug 2020
29,418
3 Jun 2019 Robert Carey
Director
Buy 19,418 $5.15 $100,003
3 Jun 2019
19,418
28 Feb 2017 Robert Carey
EVP and Chief Business Officer
Sale 31,808 $16.03 $509,882
28 Feb 2017
95,408


Sangamo Therapeutics Inc executives and stock owners

Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: